Heart Attack - Pipeline Review, H2 2014 Released On 15th October 2014
Summary Heart Attack - Pipeline Review, H2 2014, provides an overview of the Heart Attacks therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Heart Attack, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Heart Attack and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
The report provides a snapshot of the global therapeutic landscape of Heart Attack The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Heart Attack and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Heart Attack products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Heart Attack pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products
Reasons To Buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Heart Attack Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Heart Attack pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Browse Report on: JSB Market complete Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com http://www.jsbmarketresearch.com/healthcare-medical/r-heart-attackTel No- 91 2241236650 / +91 - 998 729 5242 pipeline-review-h2-2014-126958 Published by- http:/www.jsbmarketresearch.com/
Table of Contents List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Heart Attack Overview 6 Therapeutics Development 7 Pipeline Products for Heart Attack - Overview 7 Pipeline Products for Heart Attack - Comparative Analysis 8 Heart Attack - Therapeutics under Development by Companies 9 Heart Attack - Therapeutics under Investigation by Universities/Institutes 10 Heart Attack - Pipeline Products Glance 11 Early Stage Products 11 Heart Attack - Products under Development by Companies 12 Heart Attack - Products under Investigation by Universities/Institutes 13 Heart Attack - Companies Involved in Therapeutics Development 14 Lacer, S.A. 14 Aronora, LLC 15 Lanthio Pharma B.V. 16 Heart Attack - Therapeutics Assessment 17 Assessment by Monotherapy Products 17 Assessment by Target 18 Assessment by Mechanism of Action 20 Assessment by Route of Administration 22 Assessment by Molecule Type 23 Drug Profiles 25 AB-002 - Drug Profile 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 LA-8045 - Drug Profile 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Cell Therapy to Inhibit Myosin for Cardiovascular Disorders - Drug Profile 27 Product Description 27 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Mechanism of Action 27 R&D Progress 27 NVX-308 - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 LWnt-3a - Drug Profile 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Peptide to Agonize Apelin Receptor for Diabetes and Heart Failure - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Small Molecules to Inhibit PDE5 for Ischemia Reperfusion Injury - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Synthetic Peptides to Activate Complement C3 for Immunology, Cardiovascular and CNS Disorders - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Heart Attack - Dormant Projects 33 Heart Attack - Product Development Milestones 34 Featured News & Press Releases 34 Jul 15, 2014: Thymosin 4 Prevents Heart Rupture & Improves Cardiac Function after Heart Attack in Mice 34 May 27, 2014: NeoStem Announces Grant of Two U.S. Patents for CD34 Cell Program 34 May 08, 2014: FDA approves Zontivity to reduce the risk of heart attacks and stroke in highrisk patients 35 Dec 26, 2013: AstraZeneca and Shionogi settle arbitration and extend licence agreement for CRESTOR 35 Dec 23, 2013: Heart Disease Therapy Cleared for Phase 2 Clinical Trial to be Funded by Stem Cell Agency 36 Dec 17, 2013: Capricor Therapeutics Cleared to Begin Phase II Portion of ALLSTAR Clinical Trial with CAP-1002 in Patients Following Heart Attack 36 Aug 06, 2013: Athersys Announces Grant to Support Clinical Advancement of Its MultiStem Regenerative Medicine Program for Heart Attack Patients 37 Mar 11, 2013: Roches Inclacumab Shows Efficacy In Reducing Heart Damages During Artery JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Clearing Angioplasty Procedures 38 Nov 29, 2012: AstraZeneca Wins Chinese Approval For New Heart Drug Brilinta 39 Appendix 40 Methodology 40 Coverage 40 Secondary Research 40 Primary Research 40 Expert Panel Validation 40 Contact Us 41 Disclaimer 41
List Of Tables Number of Products under Development for Heart Attack, H2 2014 7 Number of Products under Development for Heart Attack - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Number of Products under Investigation by Universities/Institutes, H2 2014 10 Comparative Analysis by Early Stage Development, H2 2014 11 Products under Development by Companies, H2 2014 12 Products under Investigation by Universities/Institutes, H2 2014 13 Heart Attack - Pipeline by Lacer, S.A., H2 2014 14 Heart Attack - Pipeline by Aronora, LLC, H2 2014 15 Heart Attack - Pipeline by Lanthio Pharma B.V., H2 2014 16 Assessment by Monotherapy Products, H2 2014 17 Number of Products by Stage and Target, H2 2014 19 Number of Products by Stage and Mechanism of Action, H2 2014 21 Number of Products by Stage and Route of Administration, H2 2014 22 Number of Products by Stage and Molecule Type, H2 2014 24 Heart Attack - Dormant Projects, H2 2014 33
List Of Figures Number of Products under Development for Heart Attack, H2 2014 7 Number of Products under Development for Heart Attack - Comparative Analysis, H2 2014 8 Number of Products under Development by Companies, H2 2014 9 Number of Products under Investigation by Universities/Institutes, H2 2014 10 Comparative Analysis by Early Stage Products, H2 2014 11 Assessment by Monotherapy Products, H2 2014 17 Number of Products by Top 10 Target, H2 2014 18 Number of Products by Stage and Top 10 Target, H2 2014 19 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Number of Products by Top 10 Mechanism of Action, H2 2014 20 Number of Products by Stage and Top 10 Mechanism of Action, H2 2014 21 Number of Products by Top 10 Molecule Type, H2 2014 23 Number of Products by Stage and Top 10 Molecule Type, H2 2014 24
Product Price :
License Type
Price
$2000
Site Licence
$ 4000
Enterprise Wide Licence
$ 6000
Related reports:
Alba Therapeutics Corporation - Product Pipeline Review - 2014 Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 Clarassance, Inc. - Product Pipeline Review - 2014 Morvus Technology Ltd - Product Pipeline Review - 2014 SBI Biotech Co., Ltd. - Product Pipeline Review - 2014 Pharma Mar, S.A. - Product Pipeline Review - 2014 JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/
Maruishi Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014 Melior Discovery, Inc. - Product Pipeline Review - 2014 Memgen, LLC. - Product Pipeline Review - 2014
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com
About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on “Heart Attack - Pipeline Review, H2 2014� http://www.jsbmarketresearch.com/healthcare-medical/r-heart-attackpipeline-review-h2-2014-126958
JSB Market Research Pvt. Ltd.
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 / +91 - 998 729 5242 Published by- http:/www.jsbmarketresearch.com/